Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 2, 1999, Pages 209-215

  Wakamatsu, Kentaro ^b   Nakanishi, Yoichi ^a   Takayama, Koichi ^b   Miyazaki, Hiroyuki ^b   Hayashi, Kenshi ^b   Hara, Nobuyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHUS;

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHUS; DNA SEQUENCE; EPITHELIUM; EXON; FEMALE; GENETICS; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG DISEASE; LUNG TUMOR; MALE; METABOLISM; METAPLASIA; MIDDLE AGED; MUTATION; PATHOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHI; EPITHELIUM; EXONS; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LUNG DISEASES; LUNG NEOPLASMS; MALE; METAPLASIA; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033172699     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.2.3524     Document Type: Article

References (36)

1. Jacobson, D. R., C. L. Fishman, and N. E. Mills. 1995. Molecular genetic markers in the early diagnosis and screening of non-small-cell lung cancer. Ann. Oncol. 6(Suppl. 3):S3-S8.
2. Isobe, M., B. S. Emanuel, D. Givol, M. Oren, and C. M. Croce. 1986. Localization of gene for human p53 tumor antigen to hand 17p13. Nature 320: 84-85.
3. Finlay, C. A., P. W. Hinds, and A. J. Levine. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083-1093.
4. Minna, J. D. 1993. The molecular biology of lung cancer pathogenesis. Chest 103:449S-456S.
5. Nowell, P. C. 1986. Mechanisms of tumor progression. Cancer Res. 46:2203-2207.
6. Marshall, C. J. 1991. Tumor suppressor genes. Cell 64:313-326.
7. Vogelstein, B., E. R. Fearon, S. K. Hamilton, S. E. Kern, A. C. Preisinger, M. Leppert, Y. Nakamura, R. White, A. M. M. Smits, and J. L. Bos. 1988. Genetic alterations during colorectal tumor development. N. Engl. J. Med. 319:525-532.
8. Nuorva, K., Y. Soini, D. Kamel, D. Kamel, H. Autio-Harmainen, L. Risteli, J. Risteli, K. Vahakangas, and P. Paakko. 1993. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am. J. Pathol. 142:725-732.
9. Bennett, W. P., T. V. Colby, W. D. Travis, A. Borkowski, R. T. Jones, D. P. Lane, R. A. Metcalf, J. M. Samet, Y. Takeshima, J. R. Gu, K. H. Vahakangas, Y. Soini, P. Paakko, J. A. Welsh, B. F. Trump, and C. C. Harris. 1993. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res. 53:4817-4822.
10. Walker, C., L. J. Robertson, M. W. Myskow, N. Pendleton, and G. R. Dixon, 1994. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer 70:297-303.
11. Boers, J. E., G. P. M. Ten Velde, and F. B. J. M. Thunnissen. 1996. p53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Am. J. Respir. Crit. Care Med. 153:411-416.
12. Sozzi, G., M. Miozzo, R. Donghi, S. Pilotti, C. T. Cariani, U. Pastorino, G. Della Porta, and M. A. Pierotti. 1992. Deletions of 17p and p53 mutations in prencoplastic lesions of the lung. Cancer Res. 52:6079-6082.
13. Sundaresan, V., P. Ganly, P. Hasleton, R. Rudd, G. Sinha, N. M. Blechen, and P. Rabbitts. 1992. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7:1989-1997.
14. Mackay, B., J. M. Lukeman, and N. G. Ordonez. 1991. Premalignant lesions. In Tumors of the Lung. J. Mitchell, editor. W. R. Saunders Company, Philadelphia. 90-99.
15. Shin, R. W., T. Iwaki, T. Kitamoto, and J. Tateishi. 1991. Hydrated autoclave pretreatment enhances TAU immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab. Invest. 64:693-702.
16. Whetsell, L., G. Maw, N. Nadon, D. P. Ringer, and F. V. Schaefer. 1992. Polymerase chain reaction microanalysis of tumors from stained histological slides. Oncogene 7:2355-2361.
17. Mashiyama, S., Y. Murakami, T. Yoshimoto, T. Sekiya, and K. Hayashi. 1991. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6:1313-1318.
18. Umekita, Y., K. Kobayashi, T. Saheki, and H. Yoshida. 1994. Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer. Jpn. J. Cancer Res. 85:825-830.
19. Greenblatt, M. S., W. P. Bennett, M. Hollstein, and C. C. Harris. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-4878.
20. Harris, C. C., and M. Hollstein. 1993. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1318-1327.
21. Giaccone, G. 1996. Oncogenes and antioncogenes in lung tumurigenesis. Chest 109;130S-134S.
22. D'Amico, D., D. Carbone, T. Mitsudomi, M. Nau, J. Fedorko, E. Russel, B. Johnson, D. Buchhagen, S. Border, and R. Phelps. 1992. High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene 7:339-346.
23. Chiba, I., T. Takahashi, M. M. Nau, D. D'Amico, D. T. Curiel, T. Mitsudomi, D. I., Buchhagen, D. Carbone, S. Piantadosi, H. Koga, P. T. Reissman, D. J. Slamon, E. C. Holmes, and J. D. Minna. 1990. Mutations of p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5:1603-1610.
24. Takahashi, T., M. M. Nau, I. Chiba, M. J. Birrer, R. K. Rosenberg, M. Vinocour, M. Levitt, H. Pass, A. F. Gazdar, and J. D. Minna. 1989. p53: a frequent target for genetic abnormalities in lung cancer. Science 246:491-494.
25. Kishimoto, Y., Y. Murakami, M. Shiraishi, K. Hayashi, and T. Sekiya. 1992. Aberrations of p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res. 52:4799-4804.
26. Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53.
27. Hirano, T., B. Franzen, H. Kato, Y. Ebihara, and G. Auer. 1994. Genesis of squamous cell lung carcinoma: sequential changes of proliferation, DNA ploidy, and p53 expression. Am. J. Pathol. 144:296-302.
28. Franklin, W. A., A. F. Gazdar, J. Haney, I. I. Wistuba, F. G. La Rosa, D. Kennedy, D. M. Ritchey, and Y. E. Miller. 1997. Widely dispersed p53 mutation in respiratory epithelium: a novel mechanism for field carcinogenesis. J. Clin. Invest. 100:2133-2137.
29. Ciechanover, A., J. A. Digiusepe, B. Bercovich, A. Orian, J. D. Richter, A. L. Schwartz, and G. M. Brodeur. 1991. Degradation of nuclear oncoproteins hy the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA 88:139-143.
30. Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and U. Vogelstein. 1993. Oncoprotein mdm-2 conceals the activation domain of suppressor p53. Nature 362:857-860.
31. Momand, J., G. P. Zambetti, D. T. Olson, D. L. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
32. van den Heuvel, S. J., T. van Laar, W. M. Kast, C. J. Melief, A. Zantema, and A. J. van der Eb. 1990. Association between the cellular p53 and the adenovirus 5 E1B-55kd proteins reduces the oncogenicity of Ad-transformed cells. EMBO J. 9:2621-2629.
33. Hall, P. A., P. H. Mckee, H. P. Menage, R. Dover, and D. P. Lane. 1993. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8:203-207.
34. Ronen, D., V. Rotter, and D. Reisman. 1991. Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif. Proc. Natl. Acad. Sci. USA 88:4128-4132.
35. Shaulsky, G., A. Ben-Ze'ev, and V. Rotter. 1990. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5:1707-1711.
36. Rämet, M., K. Castren, K. Jarvinen, K. Pekkala, T. Turpeenniemi-Hujanen, Y. Soini, P. Paakko, and K. Vahakangas. 1995. p53 protein expression is correlated with benzo(a)pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis 16:2117-2124.